Launched on April 16, the sixth video of the series analyzes articles about hydroxychloroquine and the treatment of COVID-19.


Video Script:
Gustavo Batista de Menezes (Federal University of Minas Gerais, UFMG)
Andreza Fabro de Bem (University of Brasília, UnB)

Project Coordination:
Débora Foguel (Federal University of Rio de Janeiro, UFRJ)

Video Production Team:
Lucia Bianconi (Federal University of Rio de Janeiro, UFRJ) – team leader
Amanda Kelen Soares Melo (Medicine student, Federal University of Rio de Janeiro, UFRJ)

Evaluation Committee:
Helena B. Nader (Vice-President, Brazilian Academy of Sciences, ABC)
João Batista Calixto (Vice-President for the South Region, Brazilian Academy of Sciences, ABC)
Mauro Teixeira (Vice-President for the Minas Gerais and Midwest Region, Brazilian Academy of Sciences, ABC)
Lucile Winter (Board of Directors, Brazilian Society for the Advancement of Science, SBPC)


Watch the Video (in Portuguese):


Liu J, Cao R, Xu M, Wang X, Zhang H, Hu H, Li Y, Hu Z, Zhong W, Wang M. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020 Mar 18;6:16. doi: 10.1038/s41421-020-0156-0.
Zhou D, Dai SM, Tong Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother. 2020 Mar 20. pii: dkaa114. doi: 10.1093/jac/dkaa114.
Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 Mar 11:105938. doi: 10.1016/j.ijantimicag.2020.105938.
Sahraei Z, Shabani M, Shokouhi S, Saffaei A. Aminoquinolines Against Coronavirus Disease 2019 (COVID-19): Chloroquine or Hydroxychloroquine. Int J Antimicrob Agents. 2020 Mar 16:105945. Doi:10.1016/j.ijantimicag.2020.105945
Gautret et al. (2020) Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial. International Journal of Antimicrobial Agents – In Press 17 March 2020 – DOI : 10.1016/j.ijantimicag.2020.105949
Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020 Mar 10. pii: S0883-9441(20)30390-7. doi: 10.1016/j.jcrc.2020.03.005